High prevalence of the metabolic syndrome among a Swedish cohort of patients with schizophrenia

No abstract is available for this paper.

• Publication year

  2006

• Venue

  International Clinical Psychopharmacology

• Publication date

  2006-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/01.YIC.0000188215.84784.17PMID 16421460
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Metabolic Syndrome in Patients with Schizophrenia

  2015cited by this paper
• Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women.

  2004influential reference
• Schizophrenia, the metabolic syndrome and diabetes

  2004cited by this paper
• Adverse metabolic effects associated with atypical antipsychotics: literature review and clinical implications.

  2004influential reference
• The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994.

  2003influential reference
• The events registration and survey procedures in the Northern Sweden MONICA Project

  2003cited by this paper
• Risk factors for coronary heart disease in longer-term patients on antipsychotic medication: High prevalence of syndrome X

  2003influential reference
• Metabolic syndrome in patients with schizophrenia.

  2003cited by this paper
• Physical consequences of schizophrenia and its treatment: the metabolic syndrome.

  2002cited by this paper
• Atypical Antipsychotic-Induced Diabetes Mellitus

  2002cited by this paper
• Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

  2002cited by this paper
• Insulin resistance: definition and consequences.

  2001cited by this paper
• Cardiovascular morbidity and mortality associated with the metabolic syndrome.

  2001cited by this paper
• Mental disorders and cause-specific mortality

  2001cited by this paper
• Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance.

  2001cited by this paper
• Time trends in schizophrenia mortality in Stockholm County, Sweden: cohort study

  2000cited by this paper
• Antipsychotic-induced weight gain: a comprehensive research synthesis.

  1999cited by this paper
• Hypertriglyceridemia, insulin resistance, and the metabolic syndrome.

  1999cited by this paper
• Syndrome X and mortality: a population-based study. Risk Factor and Life Expectancy Research Group.

  1998cited by this paper
• Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation

  1998cited by this paper
• Prevalence of diabetes and impaired glucose tolerance in patients treated with clozapine compared with patients treated with conventional depot neuroleptic medications.

  1998cited by this paper
• Effects of Diet and Exercise in Preventing NIDDM in People With Impaired Glucose Tolerance: The Da Qing IGT and Diabetes Study

  1997cited by this paper
• Excess mortality of schizophrenia

  1997cited by this paper
• Mortality and Causes of Death in First Admitted Schizophrenic Patients

  1993cited by this paper
• Prospective analysis of the insulin-resistance syndrome (syndrome X).

  1992cited by this paper
• A polydiagnostic application of operational criteria in studies of psychotic illness. Development and reliability of the OPCRIT system.

  1991cited by this paper
• Prevention of Type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise The 6-year Malmö feasibility study

  1991cited by this paper
• Effects of Diet and Exercise in Preventing NIDDM in People With Impaired Glucose Tolerance The

  year unknowncited by this paper

• Identification of metabolism and inflammation-related biomarkers and potential drugs for schizophrenia based on comprehensive bioinformatics and machine learning.

  2026cites this paper
• Prevalence and predictors of metabolic syndrome among psychiatric patients receiving antipsychotic treatment in Africa: a systematic review and meta-analysis

  2025influential citation
• Targeted Physical Rehabilitation for Physical Function Decline in Patients with Schizophrenia: A Narrative Review

  2025cites this paper
• Nurses’ and patients’ perceptions of physical health screening for patients with schizophrenia spectrum disorders: a qualitative study

  2024cites this paper
• Study of factors associated with obesity in patients using antipsychotics in schizophrenia

  2024cites this paper
• Gender and arson: psychosocial, psychological, and somatic offender characteristics at the time of the crime

  2023cites this paper
• Analysis of metabolic syndrome and cognitive functional analysis in schizophrenic patients based on psychological intervention.

  2023cites this paper
• Clinical, Biochemical and Genetic Variables Associated With Metabolic Syndrome in Patients With Schizophrenia Spectrum Disorders Using Second-Generation Antipsychotics: A Systematic Review

  2021cites this paper
• Unveiling the Metabolic Profile of First-Episode Drug-Naïve Schizophrenia Patients: Baseline Characteristics of a Longitudinal Study Among Han Chinese

  2021cites this paper
• Effectiveness of clozapine on quality of life and functioning in patients with treatment-resistant schizophrenia

  2020cites this paper
• Motivators for patients with schizophrenia spectrum disorders to start and maintain exercising: a qualitative interview study

  2020cites this paper
• Sex differences in metabolic disorder patterns of first-episode drug-naive patients with schizophrenia.

  2020cites this paper
• Safety of Use of Clozapine in Patients With Schizophrenia With Comorbid Diabetes Mellitus

  2020cites this paper
• A health promotion intervention to improve lifestyle choices and health outcomes in people with psychosis: a research programme including the IMPaCT RCT

  2020cites this paper
• Higher prevalence of metabolic syndrome and related factors in patients with first-episode psychosis and schizophrenia: a cross-sectional study in Turkey

  2020cites this paper
• Sex-differential effects of olanzapine vs. aripiprazole on glucose and lipid metabolism in first-episode schizophrenia

  2019cites this paper
• Metabolic Side Effects of Antipsychotic Medication: An Overview

  2019cites this paper
• Association between thyroid function and metabolic syndrome in male and female schizophrenia patients.

  2019cites this paper
• Prevalence of metabolic syndrome in Iranian patients with schizophrenia: A systematic review and meta-analysis.

  2019cites this paper
• PREVALENCE OF METABOLIC SYNDROME AMONG PATIENTS WITH SCHIZOPHRENIA IN THE CENTER FOR MENTAL HEALTH – “PROLET”, PSYCHIATRIC HOSPITAL -SKOPJE

  2019cites this paper
• Second-generation antipsychotics and metabolic side-effects: Canadian population-based study

  2018cites this paper
• Metabolic Syndrome among Schizophrenic Patients: A Comparative Cross-Sectional Study in the Middle Belt of Ghana

  2018cites this paper
• [Catatonic melancoly and venous thromboembolism: A risky combination].

  2018cites this paper
• Metabolic Syndrome in Schizophrenia

  2018cites this paper
• Supporting healthy lifestyle habits in persons with mental disorders : The development of a nurse-led lifestyle intervention

  2018influential citation
• The association between rehabilitation programs and metabolic syndrome in chronic inpatients with schizophrenia.

  2018cites this paper
• Prevalence of Metabolic Syndrome among Psychiatric Inpatients: A Hospital Based Study from Kashmir.

  2017cites this paper
• Shared decision making: everyone wants it, so why isn't it happening?

  2017cites this paper
• How gender affects the pharmacotherapeutic approach to treating psychosis – a systematic review

  2017cites this paper
• Aging and comorbidity among HIV-infected individuals

  2017cites this paper
• The Prevalence of Metabolic Syndrome and Its Related Factors among Adults in Palestine: A Meta-Analysis

  2017cites this paper
• Lester Adaptation of Cardio Metabolic Measurements: An Inpatient Interventional Framework for Women with Mental Illness

  2017cites this paper
• Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large‐scale meta‐analysis of 3,211,768 patients and 113,383,368 controls

  2017cites this paper
• Sex Differences in Antipsychotic Related Metabolic Functioning in Schizophrenia Spectrum Disorders.

  2017cites this paper
• Male sex may be associated with higher metabolic risk in first-episode schizophrenia patients: A preliminary study.

  2016cites this paper
• Metabolic Syndrome in South African Patients with Severe Mental Illness: Prevalence and Associated Risk Factors

  2016cites this paper
• Most Common Side Effects of Clozapine and Their Management

  2016cites this paper
• Metabolic syndrome in patients with severe mental illness in Gorgan

  2016cites this paper
• HALOPERIDOL LEADS TO TORSE DE POINTES IN SCHIZOPHRENIC POOL

  2016cites this paper
• Altered Adipocytokine Levels and Heart Rate Variability in Schizophrenic Patients with Risk of Metabolic Syndrome.

  2016cites this paper
• Relationship Between Metabolic Syndrome and Clinical Features, and Its Personal-Social Performance in Patients with Schizophrenia

  2016cites this paper
• The metabolic syndrome in an Italian psychiatric sample: a retrospective chart review of inpatients treated with antipsychotics.

  2016cites this paper
• Association between actigraphy-derived physical activity and cognitive performance in patients with schizophrenia

  2016cites this paper
• Lithium or Valproate Adjunctive Therapy to Second-generation Antipsychotics and Metabolic Variables in Patients With Schizophrenia or Schizoaffective Disorder

  2016cites this paper
• Clozapine in Parkinsonian Rest Tremor: A Review of Outcomes, Adverse Reactions, and Possible Mechanisms of Action

  2016cites this paper
• Syndrome métabolique chez les patients schizophrènes sous antipsychotiques : analyse de la prise en charge au Centre Hospitalier Pierre Janet du Havre

  2015cites this paper
• “First do no harm.” A systematic review of the prevalence and management of antipsychotic adverse effects

  2015influential citation
• Etiology of cardiovascular disease in patients with schizophrenia: current perspectives

  2015cites this paper
• Metabolic syndrome in antipsychotic naïve patients with schizophrenia: pooled analysis of data from three Indian studies

  2015cites this paper
• Metabolic syndrome in schizophrenia - who is more to blame: FGA polypharmacy or clozapine monotherapy?

  2015cites this paper
• The brain‐derived neurotrophic factor (BDNF) Val66Met polymorphism is associated with increased body mass index and insulin resistance measures in bipolar disorder and schizophrenia

  2015cites this paper
• Prevalence of cardiovascular and metabolic events in patients prescribed clozapine: a retrospective observational, clinical cohort study.

  2015cites this paper
• Medical and Psychiatric Comorbidities: Complicating Treatment Expectations

  2014cites this paper
• Syndrome métabolique chez les sujets schizophrènes: prévalence et analyse des pratiques

  2014cites this paper
• [Prevalence of metabolic syndrome in Spanish patients with schizophrenia and overweight. The CRESSOB Study].

  2014cites this paper
• Low Prevalence of Metabolic Syndrome in a Group of Patients with Chronic Psychotic Disorders Taking Antipsychotic Polypharmacy in Residential Treatment While Adhering to a Mediterranean Diet

  2014cites this paper
• LIFEHOPE.EU: lifestyle and healthy outcome in physical education.

  2014cites this paper
• A two fold risk of metabolic syndrome in a sample of patients with schizophrenia: do consanguinity and family history increase risk?

  2014cites this paper
• Exercise for mental illness: a systematic review of inpatient studies.

  2014cites this paper
• Clozapine safety, 40 years later.

  2014cites this paper
• Prevalencia del síndrome metabólico en pacientes españoles con esquizofrenia y sobrepeso. El estudio CRESSOB

  2014cites this paper
• The metabolic syndrome in untreated schizophrenia patients: prevalence and putative mechanisms.

  2013cites this paper
• Contours of Usual Care: Meeting the Medical Needs of Diverse People with Serious Mental Illness

  2013cites this paper
• Increased Framingham 10-year CVD risk in Chinese patients with schizophrenia.

  2013cites this paper
• A comparison of cardiovascular risk factors for ten antipsychotic drugs in clinical practice

  2013cites this paper
• Relationship between SSRIs and Metabolic Syndrome Abnormalities in Patients with Generalized Anxiety Disorder: A Prospective Study

  2013cites this paper
• Metabolic syndrome in schizophrenia: Differences between antipsychotic-naïve and treated patients

  2013cites this paper
• The prevalence of metabolic syndrome and its association with alanine aminotransferase in clozapine-treated Korean patients with schizophrenia

  2013influential citation
• A Simulation Model to Estimate 10-Year Risk of Coronary Heart Disease Events in Patients with Schizophrenia Spectrum Disorders Treated with Second-Generation Antipsychotic Drugs

  2013cites this paper
• Metabolic syndrome in schizophrenia

  2013cites this paper
• A meta‐analysis of cardio‐metabolic abnormalities in drug naïve, first‐episode and multi‐episode patients with schizophrenia versus general population controls

  2013cites this paper
• The prevalence and mechanisms of metabolic syndrome in schizophrenia: a review

  2013influential citation
• C-reactive protein as a marker of cardiovascular disease in patients with a schizophrenia spectrum disorder treated in routine medical practice

  2013cites this paper
• The Correlation Between Incidence of Metabolic Syndrome and Sociodemographic and Clinical Characteristics in Schizophrenia Patients

  2013influential citation
• Metabolic syndrome in antipsychotic treated psychiatric patients.

  2013cites this paper
• Cardiovascular Disease Mortality in Chronic Schizophrenia Patients Treated with Clozapine

  2013cites this paper
• [A study of risk factors for cardiovascular disease among schizophrenic patients using the rehabilitation mental health services at Kleppur].

  2012cites this paper
• Prevalence of the Metabolic Syndrome among Outpatients with Schizophrenia or Schizoaffective Disorder

  2012cites this paper
• Venous Thromboembolism in Recipients of Antipsychotics

  2012cites this paper
• Metabolic syndrome in schizophrenia: A comparative study of antipsychotic-free/naïve and antipsychotic-treated patients from India

  2012cites this paper
• Cardiovascular Mortality and Related Risk Factors among Persons with Schizophrenia: A Review of the Published Literature

  2012cites this paper
• Rannsókn á áhættuþáttum hjarta- og æðasjúkdóma hjá geðklofasjúklingum á geðsviði Landspítala

  2012cites this paper
• Metabolic syndrome in antipsychotic naïve patients diagnosed with schizophrenia

  2012cites this paper
• Prevalence of metabolic syndrome among patients with Schizophrenia in Palestine

  2012cites this paper
• Association of plasma retinol-binding protein-4, adiponectin, and high molecular weight adiponectin with metabolic adversities in patients with schizophrenia.

  2011cites this paper
• Cross-sectional prevalence of metabolic syndrome in Korean patients with schizophrenia.

  2011cites this paper
• Prevalence of the metabolic syndrome in Danish psychiatric outpatients treated with antipsychotics

  2011cites this paper
• Gender differences in the effects of peroxisome proliferator-activated receptor γ2 gene polymorphisms on metabolic adversity in patients with schizophrenia or schizoaffective disorder.

  2011cites this paper
• Polymorphisms of INSIG2, MC4R, and LEP Are Associated With Obesity- and Metabolic-Related Traits in Schizophrenic Patients

  2011cites this paper
• Diabetes Prevalence Estimates in Schizophrenia and Risk Factor Assessment

  2011cites this paper
• Prevalence , impact of medications and disparities in health care WPA EDUCATIONAL MODULE

  2011cites this paper
• The High Prevalence of Poor Physical Health and Unhealthy Lifestyle Behaviours in Individuals with Severe Mental Illness

  2011cites this paper
• The prevalence and clinical correlates of metabolic syndrome in patients with schizophrenia: findings from a cohort in Turkey

  2011cites this paper
• Clozapine safety, 35 years later.

  2011cites this paper
• Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care

  2011cites this paper
• General practitioners’ attitudes on who should manage metabolic dysregulations associated with antipsychotics

  2011cites this paper
• Síndrome metabólico y antipsicóticos de segunda generación

  2011cites this paper
• Metabolic syndrome and psychiatrists' choice of follow-up interventions in patients treated with atypical antipsychotics in Denmark and Sweden

  2011cites this paper
• Schizophrenia patients at higher risk of diabetes, hypertension and hyperlipidemia: a population-based study.

  2011cites this paper
• Prevalence of metabolic syndrome in patients with schizophrenia

  2011cites this paper